Skip to Main Content

Author Details

Alec Paschalis
The Institute for Cancer Research
2009
25
16
PMIDPaper TitleJournal TitlePublished Year
36609007A Transgender Patient with Prostate Cancer: Lessons Learnt.Eur Urol2023
37751307The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer.J Clin Invest2023
37844613Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.Nature2023
37355762Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.Oncogene2023
34167925Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications.Eur Urol Focus2022
35552383Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer.Clin Cancer Res2022
34449248A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer.Annu Rev Pharmacol Toxicol2022
32988971Characterizing CDK12-Mutated Prostate Cancers.Clin Cancer Res2021
33495132Prostate-specific Membrane Antigen Theranostics for Prostate Cancer Care: A Need to Prove Clinical Utility.Eur Urol Focus2021
33879449RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.Cancer Discov2021
33822745JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer.Cancer Res2021
34753775HER3 Is an Actionable Target in Advanced Prostate Cancer.Cancer Res2021
34045297Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial.Cancer Discov2021
33176972Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.Eur Urol2021
32343676The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer.J Clin Invest2020
32663466Prostate Cancer 2020: "The Times They Are a'Changing".Cancer Cell2020
32653323Elucidating Durable Responses to Immune Checkpoint Inhibition.Eur Urol2020
30340782Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency.Eur Urol2019
31265359Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer.J Clin Oncol2019
31345636Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer.Eur Urol2019
31036442Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.Eur Urol2019
29555663Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC).Clin Cancer Res2018
30135575Alternative splicing in prostate cancer.Nat Rev Clin Oncol2018
29936624A systematic review of the safety and efficacy of aerobic exercise during cytotoxic chemotherapy treatment.Support Care Cancer2018
19442879beta1-Adrenoceptor distribution in the rat brain: an immunohistochemical study.Neurosci Lett2009
  • 1 - 25 of 25

Recommended Authors

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Career Start Year 2013
Number of shared co-authors 2
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 16
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 6
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 3
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 2004
Number of shared co-authors 16
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 4
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 12
University of British Columbia
Career Start Year 2002
Number of shared co-authors 3
University of British Columbia
Career Start Year 2002
Number of shared co-authors 5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2001
Number of shared co-authors 3
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 11
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 5
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2000
Number of shared co-authors 8
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 7
University College London
Career Start Year 1999
Number of shared co-authors 7
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 22
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 11
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 17
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 11
University of Bern
Career Start Year 1990
Number of shared co-authors 17
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 11
University of California Davis
Career Start Year 1988
Number of shared co-authors 5
University of British Columbia
Career Start Year 1987
Number of shared co-authors 9
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 13
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 12

Collaborators

The Institute for Cancer Research
Co-authored papers 23
The Institute for Cancer Research
Co-authored papers 17
The Institute for Cancer Research
Co-authored papers 17
The Institute of Cancer Research
Co-authored papers 15
The Institute of Cancer Research
Co-authored papers 9
The Institute of Cancer Research
Co-authored papers 8
The Institute of Cancer Research
Co-authored papers 7
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 5
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 5
University of Washington
Co-authored papers 4
UT Southwestern Medical Center
Co-authored papers 3
The Institute of Cancer Research
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
University of Michigan Medical School.
Co-authored papers 2
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Co-authored papers 1
Rowan University
Co-authored papers 1
UT Southwestern Medical Center
Co-authored papers 1
The University of Texas Southwestern Medical Center
Co-authored papers 1
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 1
Center for Systems Biology, University of Texas at Dallas
Co-authored papers 1
Theageneion Anticancer Hospital
Co-authored papers 1
University of California los angeles
Co-authored papers 1
The University of Texas at Dallas
Co-authored papers 1
Columbia University
Co-authored papers 1
Vall d'Hebron Institute of Oncology (VHIO)
Co-authored papers 1
University of California los angeles
Co-authored papers 1
UT Southwestern Medical Center
Co-authored papers 1
Southwestern Medical Center, University of Texas
Co-authored papers 1